Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.42bn | 1.46bn | 1.46bn | 1.41bn | 1.54bn | 1.57bn |
| Cost of revenue | 1.24bn | 1.26bn | 1.28bn | 1.21bn | 1.31bn | 1.33bn |
| Gross profit | 183m | 204m | 182m | 201m | 234m | 243m |
| Research and development | 29m | 29m | 33m | 32m | 27m | 33m |
| Selling, general and administrative | 163m | 163m | 160m | 166m | 153m | 176m |
| Operating expenses | 199m | 198m | 302m | 159m | 192m | 209m |
| Operating income | −16m | 6m | −120m | 42m | 42m | 34m |
| Pre-tax income | −29m | −7m | −139m | 27m | 34m | 44m |
| Income tax | 11m | 3m | 7m | 15m | 39m | 13m |
| Net income | −53m | −25m | −145m | 11m | −33m | 38m |
| Earnings per share | −0.31 | −0.14 | −0.92 | −0.03 | −0.19 | 0.13 |
| Earnings per share, diluted | −0.31 | −0.14 | −0.92 | −0.03 | −0.19 | 0.13 |
| Weighted average shares | 173m | 173m | 173m | 172m | 172m | 172m |
| Weighted average shares, diluted | 173m | 173m | 173m | 172m | 172m | 173m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 369m | 429m | 468m | 399m | 334m | 340m | 330m | 335m |
| Inventory | 885m | 818m | 836m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | −53m | — | — | −74m | — | — | — |
| Depreciation and amortisation | 73m | 73m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 896m |
| 1.03bn |
| 917m |
| 1.00bn |
| 923m |
| Current assets | 2.18bn | 2.06bn | 2.18bn | 2.21bn | 2.29bn | 2.13bn | 2.29bn | 2.25bn |
| Property, plant and equipment | 2.44bn | 2.49bn | 2.48bn | 2.49bn | 2.49bn | 2.49bn | 2.58bn | 2.55bn |
| Goodwill | 628m | 630m | 628m | 631m | 637m | 633m | 643m | 640m |
| Total assets | 7.13bn | 7.02bn | 7.08bn | 7.15bn | 7.23bn | 7.11bn | 7.33bn | 7.32bn |
| Current liabilities | 1.72bn | 1.59bn | 1.60bn | 1.54bn | 1.54bn | 1.57bn | 1.56bn | 1.73bn |
| Short-term debt | 376m | 353m | 378m | 372m | 284m | 325m | 346m | 576m |
| Long-term debt | 1.68bn | 1.66bn | 1.63bn | 1.66bn | 1.67bn | 1.51bn | 1.51bn | 1.34bn |
| Total liabilities | 4.23bn | 4.06bn | 4.08bn | 4.09bn | 4.06bn | 3.95bn | 3.99bn | 3.98bn |
| Equity | 2.68bn | 2.75bn | 2.77bn | 3.06bn | 3.17bn | 2.96bn | 3.35bn | 3.34bn |
| Shares outstanding | 173m | 173m | 173m | 173m | 173m | 172m | 172m | 172m |
| Shares issued | 264m | 263m | 263m | 263m | 263m | 263m | 263m | 263m |
| Treasury shares | 91m | 91m | 91m | 91m | 91m | 91m | 91m | 91m |
| 72m |
| 69m |
| — |
| 70m |
| 75m |
| Share-based compensation | 9m | — | — | 9m | — | — | — |
| Capital expenditure | 38m | — | — | 36m | — | — | — |
| Investing cash flow | −37m | — | — | 6m | — | — | — |
| Dividends paid | 16m | — | — | 44m | 44m | 44m | 43m |
| Share buybacks | — | — | — | 0 | — | — | — |
| Financing cash flow | 30m | — | — | 60m | — | — | — |